Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Tumors”

8,911 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,911 results

Testing effectiveness (Phase 2)Study completedNCT02311582
What this trial is testing

MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma
Washington University School of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Very early researchLooking for participantsNCT05632562
What this trial is testing

Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma

Who this might be right for
High Grade Glioma
University of Alabama at Birmingham 20
Early research (Phase 1)Study completedNCT00085488
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Active Not RecruitingNCT05739942
What this trial is testing

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Who this might be right for
Newly Diagnosed and Recurrent Glioblastoma
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)UnknownNCT05885386
What this trial is testing

A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

Who this might be right for
PheochromocytomaParaganglioma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03561870
What this trial is testing

Olaparib in Recurrent IDH-mutant Glioma

Who this might be right for
Recurrent IDHMutant High Grade Glioma
Hospices Civils de Lyon 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04792073
What this trial is testing

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT00020527
What this trial is testing

Caspofungin Acetate in Treating Children With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionKidney Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04375527
What this trial is testing

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC V8Clinical Stage IV Cutaneous Melanoma AJCC V8Locally Advanced Cutaneous Melanoma+8 more
Jonsson Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00027742
What this trial is testing

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Testing effectiveness (Phase 2)Looking for participantsNCT06893783
What this trial is testing

Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients

Who this might be right for
Neuroendocrine Carcinomas (NEC)Neuroendocrine Carcinoma of PancreasNeuroendocrine Carcinoma of Prostate
Inkeun Park 60
Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Not applicableUnknownNCT01281722
What this trial is testing

Role of SLURP-1 in Melanoma and Melanoma Stem Cells

Who this might be right for
Melanoma;
National Taiwan University Hospital 150
Early research (Phase 1)Active Not RecruitingNCT02191488
What this trial is testing

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Who this might be right for
Brain Tumors
David W. Roberts 540
Testing effectiveness (Phase 2)Study completedNCT00005961
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 40
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Not applicableStudy completedNCT04920162
What this trial is testing

Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

Who this might be right for
Melanoma and Vitiligo
Centre Hospitalier Universitaire de Nice 10
Not applicableStudy completedNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Next Page